We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.30 | 1.20 | 1.40 | 1.30 | 1.30 | 1.30 | 113,509 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/4/2018 14:42 | Yes Stig holding 2% may make you a bit biased don’t you think? And a vested interest? I too want PYC to succeed but nothing is guaranteed even if you held 12% of the company. You can’t control the future direction of the company and it’s long term success even if you do hold 2%. I was in a similar position in another company but it still went to the wall. Let’s hope your right but can we have and listen to both sides of the debate. It’s not only courtesy it’s good for your pocket! | smcl | |
26/4/2018 13:35 | That's not bad at all. And there's probably more to come. Clients plus funding. | spacedust | |
26/4/2018 13:34 | Pyc wins 4th contract in less than 6 months worth 750k plus secured 200k in funding. That's just under £1m in 5 months. | spacedust | |
26/4/2018 13:18 | These people who are trying to downplay a £48k contract with a new Biotech client are talking like the small time traders that they are. These people are 'zero sum gamers', their philosophy dictates that they only make money by taking money from other traders i.e. you. I'm a major (2%+) holder and owner of Physiomics shares. As an owner of the business, I think - getting a new client - expanding market - increasing revenue - improving cashflow are all great things and very pleased with how Physiomics management are performing for SHAREholders. Physiomics are helping their clients/customers to expand the cake so ALL parties/STAKEholders will benefit. Morally/Spiritually/ | the stigologist | |
26/4/2018 12:54 | A 500k deal resulted in 3200% rise A 50k deal should result in 320% rise But it goes down. | spacedust | |
26/4/2018 12:23 | Looking for volume to double before close. Think we'll see 5-6mil + today. | margic | |
26/4/2018 12:22 | Looking good to turn again technically on lower time frames, looks ready to pop long higher time frames, all lining up again nicely, looking for a strong finish to April. | margic | |
26/4/2018 12:20 | This will look lovely with a close above 7p. | margic | |
26/4/2018 11:31 | Well, if that's come from recent events that's another step forwards. Sets the daily pivot, ready for tomorrow. | margic | |
26/4/2018 11:15 | 48k ... hahahahahahahaha ... | buffskins | |
26/4/2018 11:14 | Probably as its aim it will add 10 p to share price lmao | babbler | |
26/4/2018 11:13 | £48k! Was it worth RNS'ing? | on target | |
26/4/2018 09:06 | 'Ahead of the game...'...their simulation is for working out dosage and frequency of administration for cancer drugs. Just cancer drugs. Something drug companies already do obviously. It's a totally non critical, though helpful service that pharmas could use on just one type of drug out of all the thousands they produce. | davevt | |
26/4/2018 08:58 | There is a wall of money targeting this personalised medicine AI area and Physiomics are genuinely ahead of the game having been working on Modelling and Simulation / Quantitative Biology / Biosimulation for almost 20 years | the stigologist | |
26/4/2018 08:37 | It's been almost 5-6 months I'm still waiting for the rinse bit, so of course there hasn't been no repeat yet. Has to rinse first of course before it can repeat for this theory. So you need a placing at the least. How much longer for this forward sold placing some quarters are hinting at?Look at the monthly chart, then the weekly, then the daily. Joint the picture, check the pull back zone, then give me a second and tell me what you reckon? Placing in that pull back time? Now look at the other recent examples, did those have a placing? Which is likeliest to be a pull back before the next long wave, then ones with the placings or without?Maybe I just see a very different picture here. 95% of the time, I agree rinse and repeat. Neither happening here yet at tall. Just one lovely almighty monthly pull back. I've bet a fair bit of dollar and say, this goes 20-32p at some point in the next 9-12 months just through natural pattern. Way beyond with great news. Below 5p with repeated placings. Placings look unlikely to me, but the share price is at a good level for the company to raise funds if needed. 10p+ all the better. If anything it would be wise to, but ask, why haven't they with the highest share price they have had in donkeys? Substantial non-dilutive funding. Access to.Nuff said one that one. | margic | |
26/4/2018 08:25 | Also took more stock during this year. Imo as the price will eventually rise back to from where it once came. | margic | |
26/4/2018 08:05 | Everything I know about the AIM is what I learned from Mike111D. | pwhite73 | |
25/4/2018 21:59 | Mike111D - surely the real one is dead by now. In heaven with his beloved ERX IP! Or perhaps hiding in secret location with ant15. The documents under the pillow. | officerdigby | |
25/4/2018 20:09 | Ignore this dose | smcl | |
25/4/2018 20:08 | Ah shut up Mike11d - Dipstick!! Erx Erx.... | smcl | |
25/4/2018 19:45 | This is sadly IMO a case of rinse and repeat as the t-traders continue to bail at a loss over the coming days and the price retreats from whence it came. The smart money booked profits late last year. | mike111d | |
25/4/2018 18:10 | 5 ish is an OK price to buy in at, that's where I have the last few times. 6 to 7 when all it does is peak to 8 on the last 3 news releases makes it a bit tight. | davevt | |
25/4/2018 16:32 | See those declining spike tops? That's the future that is | volsung |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions